This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
GlaxoSmithKline (GSK) - says complete response letter from US FDA for mepolizumab in COPD requires more clinical data to support approval. Closing price: 1,525p (Source: Company newswires)
AB Foods (ABF) - reiterates FY guidance, highlights stronger GBP hindrance. Strong FY from Primark (+5.5% at constant FX), Grocery, Agriculture and Ingredients to offset lower EU sugar prices. Closing price: 2,270p (Source: Company newswires)
UK Index Miners (GLEN, BLT, RIO, ANTO, KAZ, VED) - potentially sensitive to stronger than expected Chinese inflation figures, though threat of more US tariffs may overshadow this. (Source: FT)
RELX (REL) - completes corporate simplification, with shift from dual to single parent company. Closing price: 1,651.5p (Source: Company newswires)
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| INTL CONS. AIRLINES | IAG | -3.2% | -3.1% | -7.5% |
| ASTRAZENECA | AZN | -0.9% | -0.6% | -1.9% |
| ASHMORE | ASHM | 1.9% | 3.8% | -1.0% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research